Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent TaxesDividends payablesLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsOther Accumulated ExpensesOther Non-Current AssetsPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal Liabilities
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Pacific Health Care Organization (PFHO) Liabilities and Shareholders Equity (2016 - 2025)

Pacific Health Care Organization (PFHO) has 16 years of Liabilities and Shareholders Equity data on record, last reported at $13.3 million in Q3 2025.

  • For Q3 2025, Liabilities and Shareholders Equity rose 9.51% year-over-year to $13.3 million; the TTM value through Sep 2025 reached $51.7 million, up 7.99%, while the annual FY2024 figure was $12.4 million, 5.79% up from the prior year.
  • Liabilities and Shareholders Equity reached $13.3 million in Q3 2025 per PFHO's latest filing, roughly flat from $13.3 million in the prior quarter.
  • Across five years, Liabilities and Shareholders Equity topped out at $13.3 million in Q2 2025 and bottomed at $11.2 million in Q2 2023.
  • Average Liabilities and Shareholders Equity over 5 years is $11.9 million, with a median of $11.8 million recorded in 2022.
  • Peak YoY movement for Liabilities and Shareholders Equity: decreased 4.24% in 2023, then increased 11.49% in 2025.
  • A 5-year view of Liabilities and Shareholders Equity shows it stood at $11.3 million in 2021, then rose by 6.35% to $12.1 million in 2022, then fell by 2.49% to $11.8 million in 2023, then grew by 5.79% to $12.4 million in 2024, then grew by 6.92% to $13.3 million in 2025.
  • Per Business Quant database, its latest 3 readings for Liabilities and Shareholders Equity were $13.3 million in Q3 2025, $13.3 million in Q2 2025, and $12.7 million in Q1 2025.